gel-e's Grant - IV Round

gel-e raised a round of funding on February 20, 2018. Investors include National Science Foundation.

gel-e, formerly Remedium Technologies, develops and markets biomaterials which effectively achieve hemostasis, i.e. the halting of blood loss.…

Articles about gel-e's Grant - IV Round: